ALKBH5 and neoplasm: Low ALKBH5 protein expression (combined nuclear and cytoplasmic expression) was significantly associated with a number of clinical parameters including larger tumour size, higher nodal stage, less tubule formation, presence of vascular invasion, hormone receptor negativity, and worse NPI prognostic group (p < 0.05, Table 1).